Beijing Foyou Pharma (601089.SH) has received the registration certificate for Diclofenac Diethylamine Emulsion.

09/01/2025

GMT Eight

Beijing Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary, Fuyuan Pharmaceutical Co., Ltd. (referred to as "Fuyuan Pharma"), has received the "Drug Registration Certificate" for the Diclofenac Diethylamine Emulgel [Specification: 1% (20g: 0.2g, calculated as Diclofenac Sodium)] issued by the National Medical Products Administration (Certificate Number: 2025S00011). It is used to relieve mild to moderate pain in muscles, soft tissues, and joints.

FOUNDER HOLD (00418): Guo Song and Xu Chengjie have been appointed as executive directors.

GF Securities: How do you view the sales elasticity of passenger cars under the policy of trading in old cars for new ones?

Contact: contact@gmteight.com

Beijing Foyou Pharma (601089.SH) has received the registration certificate for Diclofenac Diethylamine Emulsion.

RECOMMEND

COSCO SHIPPING Development (02866) spent HK$3.8631 million on repurchasing 3.863 million shares on January 10th.

Youcare Pharmaceutical Group (688658.SH): YKYY025 injection is approved for FDA clinical trials.

Era Co., Ltd. (002641.SZ) issues a pre-decrease notice, with a year-on-year decrease of 42%-52% in net profit for 2024 to be between 174 million yuan and 210 million yuan.